{
    "abstract": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus, was first identified in December 2019 in Wuhan, China and spread rapidly, affecting many other countries. The disease is now referred to as coronavirus disease 2019 (COVID-19).The Italian government declared a state of emergency on 31st January 2020 and on 11th March World Health Organization (WHO) officially declared the COVID-19 outbreak a global pandemic. Although the COVID-19 incidence remained considerably lower in Sardinia than in the North Italy regions, which were the most affected, the field of prenatal screening and diagnosis was modified because of the emerging pandemic. Data on COVID-19 during pregnancy are so far limited. Since the beginning of the emergency, our Ob/Gyn Department at Microcitemico Hospital, Cagliari offered to pregnant patients all procedures considered essential by the Italian Ministry of Health. To evaluate the influence of the COVID-19 pandemic on the activities of our center, we compared the number of procedures performed from 10th March to 18th May 2020 with those of 2019. Despite the continuous local birth rate decline, during the 10-week pandemic period, we registered a 20% increment of 1st trimester combined screening and a slight rise of the number of invasive prenatal procedures with a further increase in chorionic villi sampling compared to amniocentesis. Noninvasive prenatal testing remained unvariated. The request for multifetal pregnancy reduction as a part of the growing tendency of voluntary termination of pregnancy in Sardinia increased. The COVID-19 pandemic provides many scientific opportunities for clinical research and study of psychological and ethical issues in pregnant women.",
    "authors": [
        {
            "affiliation": "Department of Obstetrics and Gynecology, Prenatal and Preimplantation Genetic Diagnosis, Fetal Therapy, Microcitemico Pediatric Hospital \"Antonio Cao\", Cagliari, Sardinia, Italy.",
            "firstname": "Giovanni",
            "initials": "G",
            "lastname": "Monni"
        },
        {
            "affiliation": "Department of Obstetrics and Gynecology, Prenatal and Preimplantation Genetic Diagnosis, Fetal Therapy, Microcitemico Pediatric Hospital \"Antonio Cao\", Cagliari, Sardinia, Italy.",
            "firstname": "Valentina",
            "initials": "V",
            "lastname": "Corda"
        },
        {
            "affiliation": "Department of Obstetrics and Gynecology, Prenatal and Preimplantation Genetic Diagnosis, Fetal Therapy, Microcitemico Pediatric Hospital \"Antonio Cao\", Cagliari, Sardinia, Italy.",
            "firstname": "Ambra",
            "initials": "A",
            "lastname": "Iuculano"
        }
    ],
    "conclusions": null,
    "copyrights": null,
    "doi": "10.1515/jpm-2020-0208",
    "journal": "Journal of perinatal medicine",
    "keywords": [
        "chorionic villous sampling",
        "coronavirus disease 2019 (COVID-19)",
        "fetal cell-free DNA",
        "non-invasive prenatal screening",
        "nuchal translucency",
        "prenatal screening diagnosis",
        "quantitative reverse transcription polymerase chain reaction",
        "severe acute respiratory syndrome coronavirus 2"
    ],
    "methods": null,
    "publication_date": "2020-07-07",
    "pubmed_id": "32628637",
    "results": null,
    "title": "Prenatal screening diagnosis and management in the era of coronavirus: the Sardinian experience.",
    "xml": "<Element 'PubmedArticle' at 0x788506a5ffb0>"
}